Skip to main content
Log in

Multi-cancer early detection blood test + current screening may be cost effective in the USA and UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hackshaw A, et al. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. British Journal of Cancer : 23 Aug 2021. Available from: URL: http://doi.org/10.1038/s41416-021-01498-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Multi-cancer early detection blood test + current screening may be cost effective in the USA and UK. PharmacoEcon Outcomes News 886, 15 (2021). https://doi.org/10.1007/s40274-021-07993-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-07993-6

Navigation